OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 111 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2015$784,000,000
-35.6%
50,000
-37.5%
0.02%
-19.0%
Q4 2014$1,217,000,000
-6.0%
80,000
-33.3%
0.02%
-4.5%
Q3 2014$1,294,000,000
-15.3%
120,000
+20.0%
0.02%
-26.7%
Q2 2014$1,527,000,000
-63.3%
100,000
-56.5%
0.03%
-62.0%
Q1 2014$4,158,000,000
+368.2%
230,000
+259.6%
0.08%
+393.8%
Q4 2013$888,000,000
-62.3%
63,959
-71.6%
0.02%
-67.3%
Q3 2013$2,358,000,000225,0000.05%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders